Annex VIII, Chapter III of EU MDR groups invasive devices into four rules — 5 through 8 — built around two questions: how the device enters the body, and for how long. Rule 6 answers the second question for devices that are surgically invasive and used transiently: normally intended for continuous use under 60 minutes. The default classification is Class IIa. What most classification-table summaries compress into a single line is the part that actually decides a file: three anatomical targets push a transient device straight to Class III, and three separate conditions push it to IIb instead — and none of those six outcomes depend on how short the procedure is.
Where Rule 6 sits in the invasive-device family
Annex VIII's invasive-device rules run in a deliberate sequence. Rule 5 covers devices invasive in body orifices that are not surgically invasive. Rules 6 through 8 cover surgically invasive devices, split by duration: Rule 6 for transient use under 60 minutes, Rule 7 for short-term use between 60 minutes and 30 days, and Rule 8 for implantable devices and long-term surgically invasive use beyond 30 days. A device's classification file has to answer the surgically-invasive-versus-not question before Rule 6 is even reachable, and the duration question before Rule 6 is the right rule rather than Rule 7 or 8. Getting the family wrong at that first step is a more common failure than misreading Rule 6's own escalation triggers once a team is actually in the right rule.
The IIa default and the three triggers that end it
Rule 6 does not ask what the device is made of or how it is held. It asks two things: is the device surgically invasive and transient, and if so, what does it touch. A surgically invasive device for transient use is Class IIa by default — unless it is intended for direct contact with the heart, the central circulatory system, or the central nervous system, in which case it is Class III. That escalation is not a duration question. A device used for ninety seconds that directly contacts the central nervous system is Class III just as surely as one used for the full 59 minutes the transient tier allows. The anatomical target overrides the duration finding entirely.
- Direct contact with the heart. Catheters, guidewires, and instruments that reach the heart itself, not adjacent structures, trigger Class III regardless of the procedure's length.
- Direct contact with the central circulatory system. MDR treats the central circulatory vessels with the same severity as the heart — a transient device reaching them does not stay at IIa.
- Direct contact with the central nervous system. Instruments and access devices used in neurosurgical or spinal procedures carry the same Class III escalation.
- None of the three applies. Only once all three anatomical triggers are ruled out does a transient surgically invasive device actually stay in play for Class IIa — subject to the separate IIb triggers below.
Rule 6 doesn't ask how long the device was in the patient. It asks where it was, for even a moment — and the heart, the central circulatory system, and the central nervous system answer that question before the clock does. Why a one-minute procedure can still be Class III
The three triggers that reach IIb instead
Where none of the three Class III anatomical triggers applies, a transient surgically invasive device still has to clear a second, separate test before the IIa default actually holds. Three further conditions move the device to Class IIb: controlled exposure to ionising radiation, a biological effect on the body or substantial absorption by it, and administration of medicinal products by means of a delivery system in a manner that is potentially hazardous. Each of these is a different kind of risk than the anatomical triggers — they are about what the device does to the body during its transient use, not where it physically sits.
- Controlled exposure to ionising radiation. A surgically invasive device that exposes the patient to controlled ionising radiation during a transient procedure escalates to IIb even without touching the heart, central circulatory system, or central nervous system.
- Biological effect or substantial absorption. A device that is wholly or mainly absorbed by the body, or that produces a biological effect beyond mechanical function, carries a different risk profile than an inert instrument and is classified accordingly.
- Hazardous medicinal-product delivery. A device that administers medicinal products through a delivery system, where the manner of operation is potentially hazardous, escalates on the same logic MDR applies to Rule 20's inhalation devices: the drug-device pairing, not the device alone, decides the risk.
Where this quietly bites
The failure mode on Rule 6 is rarely a team that ignores the rule outright. It is a device carried forward from the old directive at a class that was never re-tested against MDR's own escalation logic, or a device screened only against the duration question and never run through the anatomical and functional triggers that sit underneath it. A transient-use instrument that reaches the central circulatory system is not a borderline call — it is a Class III device that a Rule 5-versus-6 threshold check alone will never catch, because that check stops at surgically-invasive-or-not and never asks what the instrument touches. Settling the device-versus-medicinal-product borderline question matters here too: a device that also administers a medicinal product needs that determination settled before Rule 6's own IIb trigger for hazardous delivery can even be assessed correctly.
- Confirm surgically invasive, not merely invasive. Settle the Rule 5-versus-Rule 6 threshold before testing anything else.
- Confirm transient use. Under 60 minutes of continuous use, assessed per period rather than cumulative total.
- Run the three anatomical tests. Heart, central circulatory system, central nervous system — any one moves the device to Class III outright.
- Run the three functional tests. Ionising radiation, biological effect or absorption, hazardous medicinal-product delivery — any one moves the device to Class IIb.
- Rebuild the technical file to the class the test produces. Not to the class a legacy MDD file happened to carry forward.
None of this is exotic once the two tests are separated: the anatomical test that jumps straight to Class III, and the functional test that lands at IIb. What makes Rule 6 dangerous is treating a transient device's classification as settled because it has always sat at IIa, rather than as a six-condition test a Notified Body will run independently. If your invasive-device portfolio's classification predates a fresh Rule 6 review, that is where to start; our medical device regulatory strategy work and EU MDR classification strategy exist for exactly this gap.
Frequently asked questions
What counts as transient use under MDR Rule 6?
Transient use means the device is normally intended for continuous use for less than 60 minutes — the duration tier MDR applies consistently across its invasive-device rules. A device used repeatedly in short sessions is assessed on each individual period of continuous use, not the cumulative total across a procedure or a patient's treatment course.
When does a transient surgically invasive device escalate to Class III?
Rule 6's Class IIa default does not hold where the device is intended for direct contact with the heart, the central circulatory system, or the central nervous system. Any of those three anatomical targets pushes the device straight to Class III, regardless of how briefly it is in contact — the escalation is about where the device acts, not how long.
How is Rule 6 different from Rule 8?
Both sit in Annex VIII's surgically invasive family, but duration separates them. Rule 6 covers transient use — under 60 minutes. Rule 8 covers implantable devices and surgically invasive devices intended for long-term use, which MDR treats as a materially different risk profile and classifies accordingly. A device that starts as a Rule 6 transient procedure device is a different classification question entirely if its intended use shifts to implantation or long-term placement.
Sources & further reading
- Regulation (EU) 2017/745 (MDR), Annex VIII, Chapter III, Rule 6. eur-lex.europa.eu
- European Commission (MDCG). MDCG 2021-24 Rev.1 — Guidance on Classification of Medical Devices under Regulation (EU) 2017/745. health.ec.europa.eu
This article is provided for general informational purposes and reflects the regulatory landscape as of November 2026. It is not legal or regulatory advice. Confirm current MDR classification requirements with a Notified Body or qualified counsel before acting.